PACS Group (NYSE:PACS) Earns Buy Rating from Truist Financial

PACS Group (NYSE:PACS)‘s stock had its “buy” rating reaffirmed by equities researchers at Truist Financial in a report issued on Thursday, Benzinga reports. They presently have a $65.00 price target on the stock, up from their previous price target of $62.00. Truist Financial‘s price target points to a potential upside of 30.83% from the company’s previous close.

Other equities research analysts have also issued reports about the stock. Stephens boosted their target price on shares of PACS Group from $60.00 to $64.00 and gave the company an “overweight” rating in a research note on Thursday. Wall Street Zen lowered PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Weiss Ratings upgraded PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. UBS Group upped their price objective on PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Finally, Oppenheimer increased their target price on PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Seven analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $61.33.

PACS Group Stock Performance

Shares of PACS traded down $0.52 during mid-day trading on Thursday, hitting $49.68. 874,681 shares of the company traded hands, compared to its average volume of 816,441. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a 50-day moving average price of $44.64 and a two-hundred day moving average price of $40.03. PACS Group has a 1 year low of $10.31 and a 1 year high of $51.68. The stock has a market cap of $7.86 billion, a price-to-earnings ratio of 28.07, a P/E/G ratio of 1.42 and a beta of -0.14.

PACS Group (NYSE:PACS) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.05. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. The company had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.46 billion. Equities analysts anticipate that PACS Group will post 2.13 earnings per share for the current year.

Insider Buying and Selling at PACS Group

In other PACS Group news, CAO Michelle Lewis sold 3,172 shares of the stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $50.06, for a total value of $158,790.32. Following the transaction, the chief accounting officer directly owned 340,338 shares in the company, valued at approximately $17,037,320.28. This trade represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 167,434 shares of PACS Group stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $50.24, for a total transaction of $8,411,884.16. Following the transaction, the chief executive officer owned 53,954,101 shares in the company, valued at $2,710,654,034.24. This represents a 0.31% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,762,431 shares of company stock valued at $80,686,053. Insiders own 70.10% of the company’s stock.

Hedge Funds Weigh In On PACS Group

Institutional investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its position in PACS Group by 370.2% during the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock valued at $25,051,000 after purchasing an additional 614,250 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of PACS Group in the second quarter worth about $8,196,000. Principal Financial Group Inc. bought a new position in shares of PACS Group in the first quarter worth about $3,171,000. Arrowstreet Capital Limited Partnership lifted its position in shares of PACS Group by 44.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock valued at $9,274,000 after buying an additional 89,067 shares in the last quarter. Finally, Cantor Fitzgerald Investment Advisors L.P. purchased a new position in shares of PACS Group during the 3rd quarter valued at about $1,920,000.

Key Stories Impacting PACS Group

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Quarterly results beat expectations and outlook rose. PACS reported Q3 EPS of $0.63 and revenue of $1.50 billion, topping estimates; adjusted EBITDA increased 33.6%. Management raised its 2026 revenue forecast to $5.95–$6.05 billion and adjusted EBITDA outlook to $685–$695 million. Q3 earnings coverage Raised 2026 outlook
• Positive Sentiment: Expansion and facility ramp-ups may support continued growth. Recent acquisitions in Florida and Texas, along with the Eduro deal, add about 8,400 beds. Company leaders cited occupancy near 90%, while newer facilities mature and move toward higher occupancy and patient acuity. Acquisitions and results Occupancy and acquisitions
• Positive Sentiment: Analysts raised targets and maintained bullish ratings. Truist lifted its target to $65 and kept Buy; Stephens raised its target to $64 with an Overweight rating. UBS also raised its target to $67 and maintained Buy. Truist target update Stephens forecast
• Negative Sentiment: Executives and a director disclosed stock sales. CEO Jason Murray and director Mark Hancock sold shares, as did the CAO. The transactions were made under pre-arranged Rule 10b5-1 plans, and the CEO and director retained substantial holdings, which may temper concerns. Director sale CEO sale

PACS Group Company Profile

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.